Active, Not Recruiting
Siltuximab to Decrease Symptom Burden After Autologous Stem Cell Transplantation for Patients With Multiple Myeloma and AL Amyloidosis
NCT03315026
- Conditions
- AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +18 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States